EPIRUS Biopharmaceuticals, Inc. 4
4 · EPIRUS Biopharmaceuticals, Inc. · Filed Mar 1, 2016
Insider Transaction Report
Form 4
Ticktin Robert
General Counsel
Transactions
- Exercise/Conversion
Restricted Stock Units
2016-02-27−949→ 0 total→ Common Stock (949 underlying) - Exercise/Conversion
Restricted Stock Units
2016-02-27−2,134→ 6,400 total→ Common Stock (2,134 underlying) - Exercise/Conversion
Common Stock
2016-02-27+2,134→ 6,083 total - Exercise/Conversion
Common Stock
2016-02-27+949→ 3,949 total
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represented a contingent right to receive a share of the Issuer's common stock, vested in full on February 27, 2016, and had no expiration date.
- [F2]Each RSU represents a contingent right to receive a share of the Issuer's common stock, vests in four (4) substantially equal annual installments beginning on February 27, 2016 provided the Reporting Person remains continuously employed by the Issuer through each vesting date, and has no expiration date.